Table 1. Revenue forecast 2007–2012 for the global market of biomarkers by segments in US$ millions (within parenthesis in m€ based on the average currency rates of the year in question).

Market segment	2005	2006	2007	2012	CAGR (%) 2007–2012
Biomarker discovery	2.044 (1.645)	2.339 (1.864)	2.677 (1.957)	5.843 (4.546)	16.9
Clinical trials	450 (362)	625 (498)	512 (374)	1.761 (1.370)	23.5
Molecular diagnostics	1.698 (1.367)	1.95 (1.55)	2.3 (1.7)	5.156 (4.011)	17.5
Total	4.192 (3.375)	4.814 (3.837)	5.589 (4.086)	12.76 (9.93)	18

Abbreviations: CAGR, compound annual growth rate.

Source: BCC Market Research on biomarkers 2007.⁷